ESTIMATED
04/24/2024
04/24/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 4 | $2.45 | $2.45 | $2.45 |
Q2 2024 | 11 | $2.35 | $2.67 | $2.51 |
Q3 2024 | 5 | $2.40 | $2.40 | $2.40 |
Q4 2024 | 8 | $2.36 | $2.36 | $2.36 |
Q1 2025 | 5 | $2.52 | $2.52 | $2.52 |
Q2 2025 | 5 | $2.44 | $2.44 | $2.44 |
Q3 2025 | 7 | $2.40 | $2.40 | $2.40 |
Q4 2025 | 10 | $2.37 | $2.37 | $2.37 |
Q1 2026 | 4 | $2.71 | $2.71 | $2.71 |
Q2 2026 | 4 | $2.65 | $2.65 | $2.65 |
Q3 2026 | 7 | $2.56 | $2.56 | $2.56 |
Q4 2026 | 4 | $2.51 | $2.51 | $2.51 |
CME Group Inc. last posted its earnings results on Wednesday, April 24th, 2024. The company reported $2.5 earnings per share for the quarter, topping analysts' consensus estimates of $2.45 by $0.05. The company had revenue of 1.49 B for the quarter and had revenue of 5.58 B for the year. CME Group Inc. has generated $9 earnings per share over the last year ($8.86 diluted earnings per share) and currently has a price-to-earnings ratio of 22.01. CME Group Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 24th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/01/2024 | Q1 2024 | $2.35 | $1.48 B | $1.49 B | 02/28/2024 | Q4 2023 | $2.24 | $1.43 B | $1.44 B | 11/01/2023 | Q3 2023 | $2.06 | $1.34 B | 08/02/2023 | Q2 2023 | $2.14 | $1.36 B | 05/03/2023 | Q1 2023 | $2.43 | $1.41 B | $1.44 B | 02/27/2023 | Q4 2022 | $1.76 | $1.21 B | $1.21 B | 11/02/2022 | Q3 2022 | $1.89 | $1.23 B | 08/03/2022 | Q2 2022 | $1.82 | $1.24 B | 05/04/2022 | Q1 2022 | $1.98 | $1.35 B | 02/25/2022 | Q4 2021 | $1.74 | $1.17 B | $1.15 B | 11/03/2021 | Q3 2021 | $2.59 | $1.15 B | $1.11 B | 08/04/2021 | Q2 2021 | $1.42 | $1.17 B | $1.18 B | 05/05/2021 | Q1 2021 | $1.60 | $1.25 B | 02/26/2021 | Q4 2020 | $1.18 | $1.10 B | $1.10 B | 11/04/2020 | Q3 2020 | $1.15 | $1.09 B | $1.08 B | 08/05/2020 | Q2 2020 | $1.41 | $1.19 B | $1.18 B | 05/06/2020 | Q1 2020 | $2.14 | $1.52 B | 02/28/2020 | Q4 2019 | $1.31 | $1.15 B | $1.14 B | 11/06/2019 | Q3 2019 | $1.78 | $1.27 B | $1.28 B | 08/07/2019 | Q2 2019 | $1.44 | $1.28 B | $1.27 B |
---|
A. CME Group Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 24th, 2024 based off last year's report dates.
A. In the previous quarter, CME Group Inc. (NASDAQ:CME) reported $2.5 earnings per share (EPS) to beat the analysts' consensus estimate of $2.45 by $0.05.
A. The conference call for CME Group Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for CME Group Inc.'s latest earnings report can be read online.
A. CME Group Inc. (NASDAQ:CME) has a recorded annual revenue of $5.58 B.
A. CME Group Inc. (NASDAQ:CME) has a recorded net income of $5.58 B. CME Group Inc. has generated $8.87 earnings per share over the last four quarters.
A. CME Group Inc. (NASDAQ:CME) has a price-to-earnings ratio of 22.01 and price/earnings-to-growth ratio is 6.06.